In this podcast, expert clinicians will discuss new evidence on investigational agents, the anti-IL-23 and JAK inhibitors, that are in late-stage development for treating moderate to severe CD.

MedEdTalks - Gastroenterology

Efficacy and Safety of Anti-interleukin (IL) 23 and Janus Kinase (JAK) Inhibitors with Drs. William J. Sandborn and Jessica R. Allegretti

MedEdTalks Gastroenterology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. This show will focus in on gastroenterology topics, such as ulcerative colitis (UC) and Crohn’s disease and includes interviews with Dr. Peter Higgins from the University of Michigan, Dr. David Rubin from the University of Chicago and Dr. William Sandborn from the University of California, San Diego.

About

MedEdTalks - Gastroenterology